Literature DB >> 30461381

Do AB0 blood groups affect lower urinary tract symptoms?

Erdal Benli1, Abdullah Çırakoğlu1, Ercan Öğreden2, Yasemin Kaya3, Ali Ayyıldız4, Ahmet Yüce1.   

Abstract

OBJECTIVE: The aim of this study is to investigate whether there is a correlation between AB0 blood group antigens and Rhesus factor and lower urinary tract symptoms (LUTS).
MATERIAL AND METHODS: A total of 556 male patients applying to our clinic with LUTS complaints from April 2012-2015 and complying with the study criteria were included in the study. The patients were divided into two groups as those with (Group 1; n=283) and without LUTS (Group 2; n=273) complaints. The effect of blood groups on LUTS complaints was compared using univariate logistic regression analyzes.
RESULTS: According to AB0 blood groups, blood groups A (56.7%) and AB (56.9%) were most common in the LUTS group. But 0 blood group (44.1%) was the least common. According to rhesus factor, the incidence of LUTS in Rh (+), and Rh (-) groups were 48.9%, and 66.7%, respectively. Compared to 0 blood group, the LUTS incidence was 1.65, and 1.66 times higher for individuals with blood groups A, and AB, respectively. The same risk increased 2.09 times for individuals with Rhesus factor negative.
CONCLUSION: This study identified a correlation between AB0 blood group and Rhesus factor and LUTS. The risk of LUTS risk increased in individuals with blood group A Rh (). Additionally there was a clear risk increase observed for AB blood group, though this did not reach statistical significance.

Entities:  

Year:  2018        PMID: 30461381      PMCID: PMC7595007          DOI: 10.5152/tud.2018.25295

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  40 in total

1.  Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

Authors:  Annamaria Morelli; Erica Sarchielli; Paolo Comeglio; Sandra Filippi; Rosa Mancina; Mauro Gacci; Linda Vignozzi; Marco Carini; Gabriella B Vannelli; Mario Maggi
Journal:  J Sex Med       Date:  2011-08-03       Impact factor: 3.802

Review 2.  EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.

Authors:  Matthias Oelke; Alexander Bachmann; Aurélien Descazeaud; Mark Emberton; Stavros Gravas; Martin C Michel; James N'dow; Jørgen Nordling; Jean J de la Rosette
Journal:  Eur Urol       Date:  2013-03-13       Impact factor: 20.096

3.  Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.

Authors:  Zalmai Hakimi; Michelle Johnson; Jameel Nazir; Betina Blak; Isaac A O Odeyemi
Journal:  Curr Med Res Opin       Date:  2014-10-28       Impact factor: 2.580

4.  Chronic ischemia alters prostate structure and reactivity in rabbits.

Authors:  R Kozlowski; R T Kershen; M B Siroky; R J Krane; K M Azadzoi
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

5.  Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer.

Authors:  Hanne Primdahl; Hans von der Maase; Flemming B Sørensen; Hans Wolf; Torben F Ørntoft
Journal:  J Cancer Res Clin Oncol       Date:  2002-04-27       Impact factor: 4.553

6.  Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia.

Authors:  Masanori Nomiya; David Mark Burmeister; Norifumi Sawada; Lysanne Campeau; Mona Zarifpour; Tristan Keys; Charles Peyton; Osamu Yamaguchi; Karl-Erik Andersson
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

Review 7.  ABO blood group, hypercoagulability, and cardiovascular and cancer risk.

Authors:  Massimo Franchini; Emmanuel J Favaloro; Giovanni Targher; Giuseppe Lippi
Journal:  Crit Rev Clin Lab Sci       Date:  2012-08-03       Impact factor: 6.250

8.  ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.

Authors:  Samuel D Kaffenberger; Todd M Morgan; Kelly L Stratton; Adu M Boachie; Daniel A Barocas; Sam S Chang; Michael S Cookson; S Duke Herrell; Joseph A Smith; Peter E Clark
Journal:  BJU Int       Date:  2012-09-07       Impact factor: 5.588

9.  The study about physical activity for subjects with prevention of benign prostate hyperplasia.

Authors:  Ho Won Lee; Shin Ah Kim; Ji Won Nam; Mi Kyung Kim; Bo Youl Choi; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2014-09-24       Impact factor: 2.835

10.  Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.

Authors:  Guillaume Paré; Daniel I Chasman; Mark Kellogg; Robert Y L Zee; Nader Rifai; Sunita Badola; Joseph P Miletich; Paul M Ridker
Journal:  PLoS Genet       Date:  2008-07-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.